TY  - GEN
AU  - Dasí,Francisco
AU  - Dasí,Francisco
TI  - Rare Respiratory Diseases: A Personal and a Public Health Problem
SN  - books978-3-0365-3670-5
PY  - 2022///
CY  - Basel
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - Pharmacology
KW  - standard diagnosis
KW  - reference centres
KW  - clinical presentation
KW  - cilia
KW  - primary ciliary dyskinesia
KW  - alpha-1 antitrypsin deficiency
KW  - rare respiratory diseases
KW  - Mycobacterium avium
KW  - Mycobacterium intracellulare
KW  - nodular bronchiectasis
KW  - non-tuberculous mycobacteria
KW  - pulmonary aspergillosis
KW  - rare pulmonary disease
KW  - miRNA expression
KW  - exhaled breath condensate
KW  - sputum
KW  - severity
KW  - pulmonary exacerbation
KW  - alpha1 antitrypsin deficiency
KW  - augmentation therapy
KW  - replacement therapy
KW  - rare diseases
KW  - gene therapy
KW  - alpha-1-antitrypsin deficit
KW  - cystic fibrosis
KW  - neonatal respiratory distress
KW  - laterality defect
KW  - orphan diseases
KW  - PCD
KW  - immunofluorescence
KW  - antibody
KW  - ALI culture
KW  - bio-resource
KW  - primary nasal epithelium
KW  - diagnostics
KW  - Alpha-1 antitrypsin deficiency
KW  - liver disease
KW  - glutamate-oxaloacetate transaminase
KW  - glutamate-pyruvate transaminase
KW  - gamma-glutamyl transpeptidase
KW  - resilience
KW  - active lifestyle
KW  - stress levels
KW  - infection control measure
KW  - self-quarantine
KW  - flow cytometry
KW  - nasal epithelium
KW  - oxidative stress
KW  - reactive oxygen species
KW  - endoplasmic reticulum stress
KW  - antioxidant therapies
KW  - idiopathic pulmonary fibrosis
KW  - chronic obstructive pulmonary disease
KW  - bronchiectasis
KW  - asthma
KW  - emphysema
KW  - alpha1-antitrypsin deficiency
KW  - transient elastography
KW  - n/a
N1  - Open Access
N2  - Dear Colleagues, A rare disease, also known as an orphan disease, is any disease that affects a small percentage of the population. Although definitions vary from continent to continent, according to the European Union, rare diseases are those with a prevalence of less than 1 in 2000 people. Rare diseases are, in general, chronic, debilitating diseases, which in many cases threaten patients' lives. It is estimated that 1-2 million people in the European Union are affected by a rare respiratory disease, which is a public health problem. Due to the low prevalence and severity of many of these diseases, whose symptoms often initially manifest in childhood, combined efforts are needed to improve our knowledge of the pathophysiology of these diseases that will lead to the development of new, more effective treatments. Therefore, since rare respiratory diseases represent an important field in medicine, we propose this Special Issue to promote the dissemination of the latest advances in basic and clinical research in these diseases. Prof. Dr. Francisco Dasí Guest Editor
UR  - https://mdpi.com/books/pdfview/book/5262
UR  - https://directory.doabooks.org/handle/20.500.12854/81230
ER  -